Is There Growth Left in the TransMedics Tank?

Disruptive growth investing is a simple endeavor. You’re looking for companies that use technology to disrupt existing business models or create entirely new markets (called blue oceans). The size of the opportunity is referred to as the total addressable market (TAM). If you’re planning to hold a company for a decade, the TAM needs to be sufficiently large so they can grow for long periods of time. Ideally there are some recurring revenues (i.e. software-as-a-service) or, in the case of hardware companies, consumables.

Revenue growth is a proxy for market share captured so that’s our main focus. Healthy gross margins ensure that profitability can be achieved at an appropriate time (when raising capital is no longer economically viable).

Click for TransMedics company website

One company that ticks the revenue growth boxes and then some is TransMedics (TMDX). The green bars in the below chart show the strong growth TransMedics has realized since our last piece on the topic – TransMedics Stock Comes Alive with Organ Transplant Tech.

Bar chart showing TransMedics quarterly revenues
Strong growth continues while valuation declines – Credi

Become a premium member and get access to hundreds of premium articles, reports and additional content.

Nanalyze Premium is your comprehensive guide to investing in disruptive technologies. Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years.